Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Heska has partnered with MBio Diagnostics in a deal focused on bringing new point-of-care multiplex testing technology to the animal health sector.
Canadian veterinary diagnostics company Biovet has begun a Can$2.25 million ($1.75 million) expansion of its headquarters, with construction expected to be completed in July.
UK firm PBD Biotech has begun selling its blood test for bovine tuberculosis (bTB) on a global scale.
A new rabies test developed in the US could be more accurate and faster in securing results for the potentially fatal disease in animals.
The upcoming merger between leading veterinary distributor Henry Schein and Vets First Choice to create a diagnostics subsidiary has been welcomed by rival firm Heska.
IDEXX Laboratories' single account sales model which combines diagnostics with laboratory presence in the US has proved successful in Germany.
According to one expert, Zoetis' acquisition of Abaxis will aid the latter in competing against veterinary diagnostics leader IDEXX Laboratories.
UK company Abingdon Health is developing a rapid diagnostic test for bovine mastitis.
Industry leader Zoetis has signed a definitive merger agreement to acquire the second-largest veterinary diagnostics firm Abaxis.
Following damaging outbreaks of Mycoplasma bovis in New Zealand cattle, the farm-intensive country is developing a new super-fast diagnostic test for the disease.
Newly-published research on Rift Valley fever (RVF) has the potential as a foundation for developing a national syndromic surveillance system for livestock in Kenya.
US animal health firm Zomedica Pharmaceuticals has entered into a veterinary diagnostics agreement with Seraph Biosciences.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.